Previous craniopharyngioma sequencing studies have only focused on either codon hotspot mutations in BRAF and CTNNB1 or evaluations that were limited to 23- or 46-gene panels [5, 14–17]. The gene discussed is BRAF; the disease is craniopharyngioma.